This article is more than 5 years old. Information may no longer be current.
Top stories in gastroenterology: Eating crickets benefits gut health, evolving role of biosimilars in gastrointestinal diseases
Among the top stories in gastroenterology was a report on the gut health benefits of eating crickets and how biosimilars could be changing the treatment of gastrointestinal diseases.
Also, a leading clinician discusses trial for a test dietary intervention for Crohn’s disease, researchers study the role enteric infections might play in inflammatory bowel disease flares and glutamine supplements improve the symptoms of postinfectious diarrhea predominant irritable bowel syndrome. – by Janel Miller
Q&A: Eating crickets may improve gut health
The crunch of an insect might bring about visions of stepping on a water bug or cockroach as you walk down the street. But what about a crunch that is associated with snacking on insects? Read more.
Biosimilars poised to move needle in gastrointestinal diseases , but h urdles r emain
The European Medicines Agency approved the first biosimilar therapies in 2006, yet it took the passage of the Affordable Care Act in 2010 for the United States to begin playing catch-up. Read more.
VIDEO: Trial to test dietary interventions for Crohn’s
In this exclusive video, James Lewis, MD, MSCE, associate director of the Inflammatory Bowel Disease Center at Penn Medicine, and Andrea Meyer, an advocate for patients with Crohn’s disease, discuss an ongoing trial to test effectiveness of two diets in treating Crohn’s disease. Watch video.
Enteric infections might play an important role in inflammatory bowel disease flares
Non-Clostridium difficile enteric infections, such as norovirus and Escherichia coli, might have an influence on flares of inflammatory bowel disease, according to research published in the American Journal of Gastroenterology. Read more.
Glutamine supplements improve symptoms of postinfectious diarrhea predominant irritable bowel syndrome
Oral dietary glutamine supplements helped patients improve symptoms of postinfectious diarrhea predominant irritable bowel syndrome, according to research published in Gut.